Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals CorpfiledCriticalBayer Pharmaceuticals Corp
Publication of CR8212ApublicationCriticalpatent/CR8212A/en
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Thiazole And Isothizaole Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Un compuesto de la formula (I): sales del mismo, prodrogas del mismo, metabolitos del mismo, composicones farmaceuticas que contiene dicho compuesto y el uso de dicho compuesto y dichas composiciones para tratar enfermedades mediadas por raf, VEGFR, PSGFR,p38 y flt-3.A compound of the formula (I): salts thereof, prodrugs thereof, metabolites thereof, pharmaceutical compositions containing said compound and the use of said compound and said compositions for treating diseases mediated by raf, VEGFR, PSGFR, p38 and flt -3.
CR8212A2003-07-232006-01-23
OMEGA-CARBOXIARIL-DIFENIL-UREA REPLACED WITH FLUOR FOR THE TREATMENT AND PREVENTION OF DISEASES AND AFFECTIONS
CR8212A
(en)
Compounds derived from spiro-oxindole; sodium channel modulators; pharmaceutical composition comprising said compound; and use in the treatment of pain, depression, cardiovascular, respiratory, psychiatric diseases, among others.
Phthalazinone derived compounds; pharmaceutical composition comprising said compound; and use of the compound for the treatment of cardiovascular diseases, parkinson's, inflammatory diseases, multiple sclerosis, cancer, among others
Compounds derived from substituted amino-quinazolines; pharmaceutical composition comprising said compound; and use of the compound for the treatment of Alzheimer's.